Compare RYOJ & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYOJ | QTTB |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.8M | 44.3M |
| IPO Year | 2025 | N/A |
| Metric | RYOJ | QTTB |
|---|---|---|
| Price | $3.26 | $3.60 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.33 |
| AVG Volume (30 Days) | 17.8K | ★ 152.2K |
| Earning Date | 02-18-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 115.48 | N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $11,523,472.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $23.56 | ★ N/A |
| Revenue Growth | ★ 12.88 | N/A |
| 52 Week Low | $1.81 | $1.35 |
| 52 Week High | $11.43 | $6.37 |
| Indicator | RYOJ | QTTB |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 61.11 |
| Support Level | N/A | $3.22 |
| Resistance Level | N/A | $3.73 |
| Average True Range (ATR) | 0.00 | 0.27 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 73.95 |
rYojbaba Co Ltd is engaged in improving and restoring physical and mental health diminished by work-related stress through consulting and health services. The company provides consulting services to labor unions and companies wishing to build constructive relationships with labor unions and health services to osteopathic clinics and osteopathic beauty salons to alleviate physical ailments created by work-related stress.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.